Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Request
Blocked Timeslot
Restricted Timeslot
Search Exhibitors/Products
|
AbbVie |
MR Hall A1402 |
|
|
|
|
|  |  |  |
|
AbbVie |
MR Hall A1502 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1602 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1403 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1503 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1603 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1404 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1504 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1604 |
|
|
|
|
| | | |
|
AbbVie |
917 |
|
|
|
|
| | | |
|
Acrotech Biopharma |
2143 |
|
|
|
|
| | | |
|
Actinium Pharmaceuticals |
734 |
|
|
|
|
| | | |
|
Adaptive Biotechnologies Corporation |
1701 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1112 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1212 |
|
|
|
|
| | | |
|
ADC Therapeutics |
736 |
|
|
|
|
| | | |
|
Agios Pharmaceuticals |
1661 |
|
|
|
|
| | | |
|
Agios Pharmaceuticals |
MR Hall A1016 |
|
|
|
|
| | | |
|
Alexion, AstraZeneca Rare Disease |
MR Hall A1001 |
|
|
|
|
| | | |
|
Alexion, AstraZeneca Rare Disease |
MR Hall A1101 |
|
|
|
|
| | | |
|
Allucent |
1384 |
|
|
|
|
| | | |
|
American Association for Cancer Research |
2103 |
|
|
|
|
| | | |
|
American Porphyria Foundation |
1905 |
|
|
|
|
| | | |
|
American Society for Transplantation and Cellular Therapy (ASTCT) |
784 |
|
|
|
|
| | | |
|
American Society of Hematology |
1101 |
|
|
|
|
| | | |
|
American Society of Pediatric Hematology Oncology (ASPHO) |
2000 |
|
|
|
|
| | | |
|
Amgen |
MR Hall A1813 |
|
|
|
|
| | | |
|
Amgen |
451 |
|
|
|
|
| | | |
|
Amyloidosis Foundation |
1803 |
|
|
|
|
| | | |
|
Amyloidosis Support Groups |
1922 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
MR Hall A1214 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
1229 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
1328 |
|
|
|
|
| | | |
|
Aplastic Anemia and MDS International Foundation, Inc. |
477 |
|
|
|
|
| | | |
|
Arcellx |
1981 |
|
|
|
|
| | | |
|
argenx |
101 |
|
|
|
|
| | | |
|
ARUP Laboratories |
1180 |
|
|
|
|
| | | |
|
Arvinas |
171 |
|
|
|
|
| | | |
|
Ascentage Pharma |
2001 |
|
|
|
|
| | | |
|
Association for Value-Based Cancer Care |
1903 |
|
|
|
|
| | | |
|
Association of Cancer Care Centers |
1925 |
|
|
|
|
| | | |
|
Association of PAs in Oncology |
2024 |
|
|
|
|
| | | |
|
Astellas Pharma US, Inc. |
2031 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1201 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1301 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1401 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1501 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1601 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1701 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1801 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1901 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2001 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2101 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1702 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1802 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1902 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2002 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2102 |
|
|
|
|
| | | |
|
AstraZeneca |
1343 |
|
|
|
|
| | | |
|
Autolus |
1615 |
|
|
|
|
| | | |
|
Azurity Pharmaceuticals, Inc |
583 |
|
|
|
|
| | | |
|
Bayer |
2135 |
|
|
|
|
| | | |
|
Beam Therapeutics |
MR Hall A2113 |
|
|
|
|
| | | |
|
Beam Therapeutics |
1963 |
|
|
|
|
| | | |
|
Beckman Coulter Life Sciences |
100 |
|
|
|
|
| | | |
|
BeiGene |
409 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A1909 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A2009 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A1910 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A2010 |
|
|
|
|
| | | |
|
Best Buy Health |
116 |
|
|
|
|
| | | |
|
Binaytara Foundation |
2004 |
|
|
|
|
| | | |
|
Binding Site, Inc. |
2171 |
|
|
|
|
| | | |
|
Blood Cancers Today / Mashup Media |
276 |
|
|
|
|
| | | |
|
Blue Spark Technologies, Inc. |
120 |
|
|
|
|
| | | |
|
bluebird bio |
MR Hall A1514 |
|
|
|
|
| | | |
|
bluebird bio |
1261 |
|
|
|
|
| | | |
|
Blueprint Medicines |
881 |
|
|
|
|
| | | |
|
BRAZILIAN ASSOCIATION OF HEMATOLOGY, HEMOTHERAPY AND CELL THERAPY |
1914 |
|
|
|
|
| | | |
|
Caribou Biosciences, Inc. |
1173 |
|
|
|
|
| | | |
|
Catalyst Oncology |
167 |
|
|
|
|
| | | |
|
Children's Hospital of Philadelphia |
483 |
|
|
|
|
| | | |
|
Citius Oncology |
265 |
|
|
|
|
| | | |
|
City of Hope Comprehensive Cancer Center |
1573 |
|
|
|
|
| | | |
|
Cleveland Clinic Taussig Cancer Institute |
770 |
|
|
|
|
| | | |
|
Clinical Education Alliance |
142 |
|
|
|
|
| | | |
|
CLL Society |
1805 |
|
|
|
|
| | | |
|
Cogent Biosciences |
728 |
|
|
|
|
| | | |
|
College of American Pathologists |
1902 |
|
|
|
|
| | | |
|
Conexiant |
154 |
|
|
|
|
| | | |
|
Cooley's Anemia Foundation |
1900 |
|
|
|
|
| | | |
|
CRISPR Therapeutics |
1473 |
|
|
|
|
| | | |
|
CSL Behring |
1221 |
|
|
|
|
| | | |
|
Cure HHT |
2022 |
|
|
|
|
| | | |
|
Curis, Inc. |
1965 |
|
|
|
|
| | | |
|
Daiichi Sankyo |
1235 |
|
|
|
|
| | | |
|
Daiichi Sankyo |
MR Hall A1405 |
|
|
|
|
| | | |
|
Daiichi Sankyo |
MR Hall A1406 |
|
|
|
|
| | | |
|
Diamond Blackfan Anemia Canada |
1821 |
|
|
|
|
| | | |
|
Diamond Blackfan Anemia Foundation Inc. |
1823 |
|
|
|
|
| | | |
|
Doximity |
2107 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
143 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
MR Hall A2003 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
MR Hall A2103 |
|
|
|
|
| | | |
|
Eli Lilly and Company |
MR Hall A2104 |
|
|
|
|
| | | |
|
Enable Injections |
1081 |
|
|
|
|
| | | |
|
Eurasian Hematology Oncology Group |
2002 |
|
|
|
|
| | | |
|
European Hematology Association |
1482 |
|
|
|
|
| | | |
|
European School of Haematology (ESH) |
1920 |
|
|
|
|
| | | |
|
Foresight Diagnostics |
2165 |
|
|
|
|
| | | |
|
Fortrea |
372 |
|
|
|
|
| | | |
|
Foundation for Sickle Cell Disease Research |
132 |
|
|
|
|
| | | |
|
Foundation for the Accreditation of Cellular Therapy |
1901 |
|
|
|
|
| | | |
|
Foundation for Women and Girls with Blood Disorders |
2008 |
|
|
|
|
| | | |
|
Foundation Medicine |
MR Hall A1114 |
|
|
|
|
| | | |
|
Foundation Medicine |
1816 |
 |
|
|
|
| | | |
|
Galapagos |
1681 |
|
|
|
|
| | | |
|
Gamida Cell |
317 |
|
|
|
|
| | | |
|
Genentech |
123 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1011 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1012 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1013 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1014 |
|
|
|
|
| | | |
|
Genmab |
MR Hall A1213 |
|
|
|
|
| | | |
|
Genmab |
601 |
|
|
|
|
| | | |
|
Geron Inc. |
1211 |
|
|
|
|
| | | |
|
Geron Inc. |
MR Hall A1513 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
1301 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1309 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1409 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1508 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1609 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1310 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1410 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1509 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1610 |
|
|
|
|
| | | |
|
GSK |
1623 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1015 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1115 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1215 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1315 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1415 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1116 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1216 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1316 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1416 |
|
|
|
|
| | | |
|
Halia Therapeutics |
259 |
|
|
|
|
| | | |
|
Harvest Integrated Research Organization Corp. |
150 |
|
|
|
|
| | | |
|
Haymarket Oncology |
764 |
|
|
|
|
| | | |
|
HCU Network America |
1923 |
|
|
|
|
| | | |
|
HealthTree Foundation |
2016 |
|
|
|
|
| | | |
|
Histiocyte Society/Histiocytosis Association |
1913 |
|
|
|
|
| | | |
|
Ichnos Glenmark Innovation |
103 |
|
|
|
|
| | | |
|
ICON plc |
2161 |
|
|
|
|
| | | |
|
Imaging Endpoints II, LLC |
981 |
|
|
|
|
| | | |
|
Intermountain Health |
1906 |
|
|
|
|
| | | |
|
International Myeloma Foundation |
580 |
|
|
|
|
| | | |
|
International Myeloma Society |
1817 |
|
|
|
|
| | | |
|
Invivoscribe, Inc. |
217 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
MR Hall A1312 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
467 |
|
|
|
|
| | | |
|
IQVIA Biotech |
681 |
|
|
|
|
| | | |
|
IQVIA Laboratories |
683 |
|
|
|
|
| | | |
|
JAMA Network |
1927 |
|
|
|
|
| | | |
|
Jazz Pharmaceuticals |
1651 |
|
|
|
|
| | | |
|
Jazz Pharmaceuticals |
MR Hall A1110 |
|
|
|
|
| | | |
|
Johnson & Johnson |
1315 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1002 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1102 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1003 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1103 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1004 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1104 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1005 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1105 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1006 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1106 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1107 |
|
|
|
|
| | | |
|
Johnson & Johnson |
MR Hall A1207 |
|
|
|
|
| | | |
|
Karyopharm Therapeutics Inc. |
1743 |
|
|
|
|
| | | |
|
Kura Oncology |
MR Hall A1613 |
|
|
|
|
| | | |
|
Kura Oncology |
601 |
|
|
|
|
| | | |
|
Legend Biotech |
401 |
|
|
|
|
| | | |
|
Lunaphore |
1982 |
|
|
|
|
| | | |
|
Machaon Diagnostics, Inc. |
475 |
|
|
|
|
| | | |
|
Mallinckrodt Pharmaceuticals |
1863 |
|
|
|
|
| | | |
|
Mechatronics Instruments B.V. |
2079 |
|
|
|
|
| | | |
|
Med Learning Group |
1781 |
|
|
|
|
| | | |
|
Med Learning Group |
971 |
|
|
|
|
| | | |
|
MedGenome |
165 |
|
|
|
|
| | | |
|
Medpace Inc. |
2121 |
|
|
|
|
| | | |
|
Medscape Oncology & Hematology |
443 |
|
|
|
|
| | | |
|
Melinta Therapeutics |
1381 |
|
|
|
|
| | | |
|
Menarini Silicon Biosystems |
1775 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1911 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2011 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1912 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2012 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1913 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2013 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2112 |
|
|
|
|
| | | |
|
Merck & Co., Inc. |
201 |
|
|
|
|
| | | |
|
Miltenyi Biomedicine GmbH |
1271 |
|
|
|
|
| | | |
|
Mission Bio |
2129 |
|
|
|
|
| | | |
|
MJH Life Sciences |
361 |
|
|
|
|
| | | |
|
Moffitt Cancer Center |
2015 |
|
|
|
|
| | | |
|
National Blood Clot Alliance |
1921 |
|
|
|
|
| | | |
|
National Comprehensive Cancer Network (NCCN) |
1801 |
|
|
|
|
| | | |
|
NMDP |
780 |
|
|
|
|
| | | |
|
Northside Hospital |
113 |
|
|
|
|
| | | |
|
Northwell Health |
2026 |
|
|
|
|
| | | |
|
Novartis |
642 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1703 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1803 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1903 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1704 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1804 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1904 |
|
|
|
|
| | | |
|
Novo Nordisk Healthcare AG |
1161 |
|
|
|
|
| | | |
|
NURIX |
865 |
|
|
|
|
| | | |
|
Ochsner Health |
146 |
|
|
|
|
| | | |
|
Ohio State’s Comprehensive Cancer Center–James Cancer Hospital & Solove Research Institute |
181 |
|
|
|
|
| | | |
|
Ohio State’s Comprehensive Cancer Center–James Cancer Hospital & Solove Research Institute |
V100 |
|
|
|
|
| | | |
|
OHSU Knight Cancer Institute |
1809 |
|
|
|
|
| | | |
|
Omeros Corporation |
769 |
|
|
|
|
| | | |
|
ONO PHARMA |
2063 |
|
|
|
|
| | | |
|
ONO PHARMA |
MR Hall A1113 |
|
|
|
|
| | | |
|
Ontada |
174 |
|
|
|
|
| | | |
|
Orca Bio |
1011 |
|
|
|
|
| | | |
|
Ossium Health, Inc. |
112 |
|
|
|
|
| | | |
|
Parexel |
260 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2106 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2107 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2108 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2109 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2110 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
MR Hall A2111 |
|
|
|
|
| | | |
|
Pfizer, Inc. |
1843 |
|
|
|
|
| | | |
|
PharmaEssentia Corporation |
1501 |
|
|
|
|
| | | |
|
Pixelgen Technologies |
182 |
|
|
|
|
| | | |
|
Platelet Disorder Support Association |
2012 |
|
|
|
|
| | | |
|
Precision for Medicine |
671 |
|
|
|
|
| | | |
|
Predicine |
156 |
|
|
|
|
| | | |
|
Protagonist Therapeutics, Inc |
1111 |
|
|
|
|
| | | |
|
PSI CRO |
1871 |
|
|
|
|
| | | |
|
Rapid Novor Inc. |
2106 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
MR Hall A1914 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
670 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
672 |
|
|
|
|
| | | |
|
Rigel Pharmaceuticals |
1601 |
|
|
|
|
| | | |
|
Roswell Park Comprehensive Cancer Center |
2179 |
|
|
|
|
| | | |
|
Sanguina, Inc. |
481 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1605 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1705 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1805 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1905 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A2005 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1505 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1606 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1706 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1806 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A1906 |
|
|
|
|
| | | |
|
Sanofi |
MR Hall A2006 |
|
|
|
|
| | | |
|
Sanofi |
943 |
|
|
|
|
| | | |
|
Sarah Cannon Research Institute |
1580 |
|
|
|
|
| | | |
|
Saudi Society of Blood & Marrow Transplantation (SSBMT) |
1912 |
|
|
|
|
| | | |
|
Scopio Labs |
584 |
|
|
|
|
| | | |
|
Sebia |
2009 |
|
|
|
|
| | | |
|
Secura Bio Inc. |
1373 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1313 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1413 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
461 |
|
|
|
|
| | | |
|
Silence Therapeutics |
1383 |
|
|
|
|
| | | |
|
Siteman Cancer Center |
2020 |
|
|
|
|
| | | |
|
SOBI, Inc |
1643 |
|
|
|
|
| | | |
|
SOBI, Inc |
MR Hall A2015 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1815 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1915 |
|
|
|
|
| | | |
|
Society for Immunotherapy of Cancer (SITC) |
2014 |
|
|
|
|
| | | |
|
Society of Hematologic Oncology |
1813 |
|
|
|
|
| | | |
|
Sophorum Consulting |
685 |
|
|
|
|
| | | |
|
Spark Therapeutics, Inc. |
136 |
|
|
|
|
| | | |
|
St. Jude Children's Research Hospital |
1915 |
|
|
|
|
| | | |
|
Star Therapeutics |
104 |
|
|
|
|
| | | |
|
Stemline Therapeutics, Inc. |
MR Hall A1007 |
|
|
|
|
| | | |
|
Stemline Therapeutics, Inc. |
1562 |
|
|
|
|
| | | |
|
Sumitomo Pharma America |
1675 |
|
|
|
|
| | | |
|
Sutter Health |
2169 |
|
|
|
|
| | | |
|
Syndax Pharmaceuticals, Inc. |
MR Hall A2004 |
|
|
|
|
| | | |
|
Syndax Pharmaceuticals, Inc. |
957 |
|
|
|
|
| | | |
|
Syneos Health |
619 |
|
|
|
|
| | | |
|
Taiho Oncology Commercial |
2021 |
|
|
|
|
| | | |
|
Taiho Oncology Commercial |
1609 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1709 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1809 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1710 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1810 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1711 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1811 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1712 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1812 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1713 |
|
|
|
|
| | | |
|
Takeda |
1242 |
|
|
|
|
| | | |
|
Team Telomere |
1811 |
|
|
|
|
| | | |
|
Telo Genomics |
785 |
|
|
|
|
| | | |
|
The Japanese Society of Hematology |
1916 |
|
|
|
|
| | | |
|
The Leukemia & Lymphoma Society |
1717 |
|
|
|
|
| | | |
|
The MDS Foundation, Inc. |
1815 |
|
|
|
|
| | | |
|
Theradex Oncology |
117 |
|
|
|
|
| | | |
|
ThermoFisher |
2071 |
|
|
|
|
| | | |
|
UCI Health |
1807 |
|
|
|
|
| | | |
|
United Porphyrias Association |
1911 |
|
|
|
|
| | | |
|
Vaniam Group |
775 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1210 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1211 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1311 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
1831 |
|
|
|
|
| | | |
|
Waldenstrom's Macroglobulinemia Foundation |
1908 |
|
|
|
|
| | | |
|
Wolters Kluwer |
2007 |
|
|
|
|
| | | |
|
Worldwide Clinical Trials |
160 |
|
|
|
|
| | | |
|
Wuhan Kindstar Medical Laboratory Limited Company |
1181 |
|
|
|
|
| | | |
|
X4 Pharmaceuticals |
730 |
|
|
|
|
| | | |
|
Y-mAbs Therapeutics, Inc. |
1282 |
|
|
|
|
| | | |